Targeting loss of heterozygosity for cancer-specific immunotherapy is a research paper published in Proceedings of the National Academy of Sciences (2021). On theSindex it has a DataRank of 0.652. It has been cited 76 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.652
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Burroughs Wellcome Fund
Grant: N/A
NCI NIH HHS
Grant: P30 CA006973
NCI NIH HHS
Grant: U01 CA230691
HHS | National Institutes of Health
Grant: T32 AR048522
NCI NIH HHS
Grant: T32 CA009071
HHS | National Institutes of Health
Grant: T32 GM73009
HHS | National Institutes of Health
Grant: R37 CA230400
HHS | National Institutes of Health
Grant: 5T32CA009071-38
Molecular Targets for Cancer Detection and Treatment
NIGMS NIH HHS
Grant: T32 GM136577
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 2T32AR048522-06
Multidisciplinary Rheumatology Training Program
National Institutes of Health
Grant: 5R37CA230400-05
Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid
FWCI
4.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals